Fingerprint
Dive into the research topics of 'Cost-effectiveness of buprenorphine–naloxone versus extended-release naltrexone to prevent opioid relapse'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of buprenorphine–naloxone versus extended-release naltrexone to prevent opioid relapse
Sean M. Murphy, Kathryn E. McCollister, Jared A. Leff, Xuan Yang, Philip J. Jeng, Joshua D. Lee, Edward V. Nunes, Patricia Novo, John Rotrosen, Bruce R. Schackman
Research output: Contribution to journal › Article › peer-review